Background Autism spectrum disorder (ASD) is a neurodevelopmental condition estimated
to affect 1 in 66 children in Canada and 1 in 270 individuals worldwide. As effective …

Objective The use of medical cannabis among people with epilepsy (PWE) has been
garnering increasing interest. In this scoping review, we aimed to summarize the literature …

Abstract Aims and Objectives Myalgic encephalomyelitis (ME), also called chronic fatigue
syndrome (CFS), is characterised by persistent fatigue, postexertional malaise, and …

Background The use of recreational cannabis by adults was legalized in Canada in 2018
(The Cannabis Act, 17 October 2018). This change in drug policy indirectly opened the …

The legalization of cannabis in Canada instantiates principles of harm-reduction and safe
supply. However, in-depth understanding of values at stake and attitudes toward legalization …

Objective: An increasing number of children and youth in Canada are taking medical
cannabis for complex medical conditions. While they deserve safe and consistent access to …

Background: The use of cannabis for medical purposes by pediatric patients is expanding
across Canada; however, supporting evidence, federal regulations and treatment guidelines …

Objectives Guidance is lacking for medical cannabis use in Canadian schools in both
legislation and approach; the impact of ambiguous policy on patient care is unknown. A …

Interest in using cannabis products for a medical purpose in children under the age of 18
years is increasing. There are many medical cannabis products available that can include …

OBJECTIVE Data evaluating the use of unlicensed cannabidiol (CBD) products for the
treatment of symptoms associated with anxiety and neurodevelopmental disorders in …